Stories
Slash Boxes
Comments

SoylentNews is people

posted by janrinok on Wednesday July 29 2015, @07:03PM   Printer-friendly
from the LHC-pays-dividends dept.

CERN, home of the 27-kilometre Large Hadron Collider (LHC), is developing a new particle accelerator just two metres long.

The miniature linear accelerator (mini-Linac) is designed for use in hospitals for imaging and the treatment of cancer. It will consist of four modules, each 50cm long, the first of which has already been constructed. "With this first module we have validated all of the stages of construction and the concept in general", says Serge Mathot of the CERN engineering department.

Designing an accelerator for medical purposes presented a new technological challenge for the CERN team. "We knew the technology was within our reach after all those years we had spent developing Linac4," says Maurizio Vretenar, coordinator of the mini-Linac project. Linac4, a larger accelerator designed to boost negative hydrogen ions to high energies, is scheduled to be connected to the CERN accelerator complex in 2020.

The miniature accelerator is a radiofrequency quadrupole (RFQ), a component found at the start of all proton accelerator chains. RFQs are designed to produce high-intensity beams. The challenge for the mini-Linac was to double the operating frequency of the RFQ in order to shorten its length. This desired high frequency had never before been achieved. "Thanks to new beam dynamics and innovative ideas for the radiofrequency and mechanical aspects, we came up with an accelerator design that was much better adapted to the practical requirements of medical applications," says Alessandra Lombardi, in charge of the design of the RFQ.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 3, Informative) by PiMuNu on Thursday July 30 2015, @07:39AM

    by PiMuNu (3823) on Thursday July 30 2015, @07:39AM (#215786)

    It is an isotope production machine, so the idea is to fire low energy protons onto a target to produce radioisotopes. The radioisotopes are then injected into patients and the resultant decay particles (probably gammas) are monitored in order to image blood flow and so forth. Another interesting idea for radioisotopes is to inject an unstable alpha emitter onto a cancer site, in order to kill cancer cells in the vicinity of the tumour.

    It is *not* a hadron/proton therapy machine. So the idea is not to bombard a cancer site with protons to kill the cells in the vicinity of the tumour. As others have commented, that is order 100 M$ facility, typically requiring few 100 MeV cyclotron.

    Note I am not a medic, I am a physicist, and I don't work on these sorts of things, so I may have got the medical stuff wrong.

    Starting Score:    1  point
    Moderation   +1  
       Informative=1, Total=1
    Extra 'Informative' Modifier   0  
    Karma-Bonus Modifier   +1  

    Total Score:   3  
  • (Score: 2) by PiMuNu on Thursday July 30 2015, @07:50AM

    by PiMuNu (3823) on Thursday July 30 2015, @07:50AM (#215789)

    In fact, reading again, it looks like it is an injector for a radioisotope cyclotron which has yet to be designed. The article is a bit hazy on details.

  • (Score: 0) by Anonymous Coward on Wednesday August 05 2015, @04:28AM

    by Anonymous Coward on Wednesday August 05 2015, @04:28AM (#218342)

    This link: http://cds.cern.ch/journal/CERNBulletin/2015/26/?ln=en [cds.cern.ch] seems to say that they do intend the design to be used for hadron therapy as well:

    The RFQs used for physics are designed to produce high-intensity beams, but this “mini-RFQ” is able to produce low-intensity beams of just a few microamps that are stable beams (no significant losses) and are grouped at a frequency of 750 MHz. These specifications make the “mini-RFQ” a perfect injector for the new generation of high-frequency compact linear accelerators used for the treatment of cancer with particles (hadron therapy). In addition, its small size belies its remarkable power: the “mini-RFQ” accelerates beams to an energy of 2.5 MeV per metre, compared to less than one MeV per metre for a classic RFQ.